StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
SKIN

SkinHealth Systems Inc.

SKIN Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$0.70
+0.02 +3.40%

Key statistics

from XBRL data in SEC filings
Market cap
$90.6M
Revenue (TTM)
$296M
Net income (TTM)
-$6.03M
EPS (TTM)
$-0.13
P/E ratio
Dividend yield
Free cash flow
$37.2M
Cash
$204M
Total assets
$473M
Gross margin
64.9%
52-week range
$0.55 – $2.69

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jun 22, 2026 8-K Shareholder vote results Jun 16, 2026 8-K/A Director or officer change May 21, 2026 8-K Delisting notice or listing-rule failure May 12, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change May 6, 2026 8-K Director or officer change; Amended charter or bylaws; Regulation FD disclosure Apr 22, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Other events Mar 6, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Director or officer change; Regulation FD disclosure Nov 3, 2025 8-K/A Director or officer change Oct 17, 2025 8-K Director or officer change; Regulation FD disclosure Sep 30, 2025 8-K Entered a material agreement Sep 4, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Amended charter or bylaws; Other events Aug 1, 2025 8-K Shareholder vote results Jun 17, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity May 27, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure May 21, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 12, 2025 8-K Results of operations (earnings release) Mar 12, 2025 8-K Director or officer change; Regulation FD disclosure Feb 28, 2025 8-K Director or officer change; Regulation FD disclosure Dec 17, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K/A Director or officer change Nov 12, 2024 8-K Director or officer change Oct 15, 2024 8-K Director or officer change Aug 30, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 11, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K/A Director or officer change May 2, 2024